The critical need to accelerate cerebral palsy research with consumer engagement, global networks, and adaptive designs.
Sruthi P Thomas, Iona Novak, Anina Ritterband-Rosenbaum, Karin Lind, Annabel Webb, Paul Gross, Maria McNamara
PMID 38552123WHAT IT FOUND
This paper argues for changing how cerebral palsy research is conducted, not how patients are treated.
It reviews strategies to speed up trials but provides no evidence on the effectiveness of any clinical intervention for therapists to use.
What this paper is
This is an editorial and strategic review advocating for specific research methodologies in cerebral palsy, such as consumer engagement, global networks, and adaptive trial designs. It discusses the history and potential benefits of these approaches but reports no new patient data, clinical outcomes, or direct evidence on the efficacy of any treatment. There are no findings here to change your clinical practice.
What it does not show
The paper is a theoretical and strategic review, not an empirical study. It does not report data from patients or outcomes of interventions. Claims about the benefits of adaptive designs are based on examples from other fields (like oncology) or future potential, not current evidence in cerebral palsy care.
The easy way to misread this
Do not interpret the discussion of adaptive trial designs or global networks as evidence that any specific treatment for cerebral palsy is more or less effective. This paper discusses the machinery of research, not the clinical results of that research.